GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
4.7k
c/trialwatch·posted 2 years ago by u/foam_head_fred

[Meta] proposal — a flair for STEP posts

Paper Clean Column ×2 Slow Clap ×1 Receipts ×3

Week 73 update. 19kg down from the start, early fullness basically gone since about week 30.

Things that worked: consistency, protein at breakfast, walking more than I want to. Things that did not: everything I bought on the internet to help with early fullness.

The part that surprised me is how much of this is admin. Ordering, storing, logging, remembering. Nobody mentions that the hard bit is not the drug, it is the routine.

Happy to answer anything. Please do not ask me what dose you should be on.

7,575 up / 2,844 down73% upvoted35 commentsid 5ic0on5 Jul 2024

35 comments

25 in this archive, depth 5

best — the order this archive was captured in

u/valeria_karlsen707 points·2 years ago

The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.

replysharereportpermalink
u/trialwatch_theoMOD386 points·2 years ago

Removed a chain here. The rule is one line long and it is not negotiable.

replysharereportpermalink
u/laila_almeida526 points·2 years ago

Which trial and what was the primary endpoint?

replysharereportpermalink
u/zaid_roos224 points·2 years ago·edited

number-needed-to-treat is the house dialect

replysharereportpermalink
u/karl_fischer_kev123 points·2 years ago

absolute risk reduction, not relative risk reduction, that is how you decide

replysharereportpermalink
u/camila_vasquez428 points·2 years ago

This is correct. Discontinuation arms show the regain reality.

replysharereportpermalink
u/milan_villalobos107 points·2 years ago

Mechanistically the bit that matters is SELECT. It explains most of the early profile and a decent chunk of the outcome.

replysharereportpermalink
u/receipts_or_nothingvetting75 points·2 years ago

Mechanistically the bit that matters is SELECT.

Yes, exactly this, and it is the bit that took me 52 weeks to accept.

replysharereportpermalink
u/first_hundred328 points·2 years ago
yep. 58 weeks in, same.
replysharereportpermalink
u/ewan_tulloch109 points·2 years ago

Sceptical. If this were true we would see it reflected in the data and we do not.

replysharereportpermalink
u/foam_head_fredOP62 points·2 years ago

absolute risk reduction, not relative risk reduction, that is how you decide

replysharereportpermalink
u/foam_head_fredOP58 points·2 years ago

SELECT reported a SURMOUNT hazard ratio but the absolute event rate is what changes clinical practice.

replysharereportpermalink
u/curious_panel_only203 points·2 years ago
tl;dr for anyone scrolling: TRIUMPH
replysharereportpermalink
u/sten_palacios153 points·2 years ago

give the trial name, phase, n, and primary endpoint in the body

replysharereportpermalink
u/anders_kuusela76 points·2 years ago

STEP, SURMOUNT, SURPASS, SELECT, FLOW, TRIUMPH — read the appendix

replysharereportpermalink
u/hedda_adeyemi176 points·2 years ago

phase 2 is not phase 3, smaller n and shorter trial

replysharereportpermalink
u/slow_logbook_notes30135 points·2 years ago

Disagree but this is the good kind of wrong — it is specific enough to be checked.

replysharereportpermalink
u/karl_fischer_kev59 points·2 years ago

the relative risk reduction in headlines is not the whole story

replysharereportpermalink
u/foam_head_fredOP77 points·2 years ago

Strongly agree. Phase 2 is investigational, not conclusive.

replysharereportpermalink
[deleted]28 points·2 years ago

[deleted]

replysharereportpermalink
u/eu_apotheke_a69 points·2 years ago

What was the dropout rate?

replysharereportpermalink
u/bastian_ekstrom136 points·2 years ago

event rates are more informative than hazard ratios alone

replysharereportpermalink
u/nightowl_injector40 points·2 years ago

the 21 week readout is different from the 27 week readout

replysharereportpermalink
u/rina_sobczak102 points·2 years ago

give the trial name, phase, n, and primary endpoint in the body

replysharereportpermalink
u/enzo_ferrari84 points·2 years ago

the relative risk reduction in headlines is not the whole story

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.